Scientifica Venture Capital

Founded in 2021, Scientifica Venture Capital is a venture capital firm based in Rome, Italy. The firm seeks to make investments in advanced manufacturing, advanced materials, artificial intelligence and quantum technologies sectors.

Riccardo D'Alessandri

Managing Partner

9 past transactions

Plantbit

Pre Seed Round in 2024
PlantBit is a technology company that manufactures sensors and provides services for smart farming. Its core product is an electrochemical sensor designed to monitor plant health by detecting early signs of water stress. This sensor sends alerts to farmers or automated systems, allowing them to optimize water usage, minimize waste, and enhance production efficiency.

Aviogel

Seed Round in 2024
Aviogel offers cutting-edge technology solutions for dealing with environmental issues.

CyLock

Seed Round in 2024
CyLock is a cybersecurity company that specializes in anti-hacker software aimed at protecting systems from cyber attacks. The software identifies vulnerabilities within various digital platforms, including websites, e-commerce sites, applications, and corporate networks. By leveraging artificial intelligence, CyLock provides services such as threat intelligence, data breach management, and personalized penetration tests. This allows small and medium-sized businesses to evaluate and strengthen their digital defenses against potential threats. Regular assessments of digital tools and employee skills are essential, as companies that neglect these practices face increased risks of cyber attacks that can lead to significant operational disruptions and financial losses. CyLock's solutions empower organizations to proactively address their security weaknesses and enhance their overall cybersecurity posture.

RECORNEA

Venture Round in 2024
Recornea is a company focused on developing a corneal medical device aimed at restoring the natural curvature of the cornea, providing clear and predictable clinical outcomes. Their technology involves an implantable medical solution designed to improve vision for patients with keratoconus and other conditions that deform the cornea. This approach enables healthcare professionals to effectively treat various pathological conditions affecting the cornea.

Space Product and Innovation

Seed Round in 2024
Space Product and Innovation specializes in modularity solutions for the space sector, focusing on satellite integration. The company develops multipurpose adapter products that enhance existing satellite systems by connecting sub-system connectors and integrating software without requiring additional drivers. This innovative approach allows spacecraft designers to streamline their processes, saving time and reducing production costs. Their offerings include a range of services such as avionics, software architecture, assembly, integration, and testing, all aimed at transforming satellites into more efficient modular systems.

OhmSpace

Seed Round in 2023
OhmSpace is a company focused on advancing spacecraft propulsion technology by developing high-performance resistojets. These thrusters utilize a low-pressure water propellant that is heated and expelled to generate thrust, providing an alternative to traditional chemical reaction methods. OhmSpace's resistojets can operate continuously for extended periods, allowing space agencies to enhance their mission capabilities while simultaneously reducing operational costs. The company's innovative approach aims to improve efficiency and effectiveness in the satellite market, making it a valuable player in the field of space propulsion.

QuantaBrain

Seed Round in 2023
QuantaBrain purpose is to accelerate the diagnosis of psychiatric and neurodevelopmental diseases by applying artificial intelligence.

GenomeUp

Convertible Note in 2023
GenomeUp is a Rome-based healthtech startup that specializes in AI-powered solutions for genetic analysis and clinical decision support. The company aims to serve as a global reference platform to enhance clinical decision-making for hospitals, laboratories, research centers, and pharmaceutical companies. By providing tools that accelerate diagnosis times and improve patient care, GenomeUp seeks to deliver actionable insights for health prevention within a 24-hour timeframe. Emphasizing its commitment to social responsibility, the company has evolved into an Italian Benefit Corporation, prioritizing sustainable and transparent practices that consider the well-being of stakeholders, communities, and the environment.

Relicta

Private Equity Round in 2022
Relicta is a company based in Sassari, Italy, focused on creating water-soluble bioplastic products derived from fish processing waste. It specializes in developing environmentally friendly packaging solutions that are biodegradable and compostable, addressing the increasing demand for sustainable materials. The company's process involves transforming fish industrial waste into a transparent and odorless plastic film, offering an innovative alternative to traditional plastic packaging. By utilizing waste materials, Relicta not only contributes to reducing environmental impact but also supports a circular economy in the packaging industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.